Abstract
Proliferator-activated receptor gamma (PPARgamma) is a nuclear receptor, which mainly associates with adipogenesis, but also appears to facilitate cell differentiation or apoptosis in certain malignant cells. This apoptosis induction by PPARgamma is increased by co-stimulation with tumor necrosis factor (TNF)-alpha-related apoptosis-inducing ligand (TRAIL), a member of the TNF family. In this study, we investigated the effect of PPARgamma on Fas-mediated apoptosis in hepatocellular carcinoma (HCC) cell lines. PPARgamma was expressed on all seven HCC cell lines and located in their nuclei. 15-Deoxy-Delta-12,14-prostaglandin J2 (15d- PGJ2), a PPARgamma ligand, inhibited cellular proliferation in HepG2, SK-Hep1 or HLE cells, unlike pioglitazone, another PPARgamma ligand, which did not have a significant influence on proliferation of these cells. However, 15d-PGJ2 facilitated Fas-mediated HCC apoptosis that could not be induced by Fas alone. These results suggest that PPARgamma can augment TNF-family-induced apoptosis.
References
Jun 2, 1995·The Journal of Biological Chemistry·J M LehmannS A Kliewer
Dec 1, 1995·Cell·B M FormanR M Evans
Dec 15, 1995·The Journal of Biological Chemistry·S L ShyngD A Harris
Dec 1, 1995·Immunity·S R WileyC A Smith
Feb 7, 1997·Cell·S Nagata
Jul 25, 1997·The Journal of Biological Chemistry·L FajasJ Auwerx
Jan 1, 1997·Advances in Experimental Medicine and Biology·F J Gonzalez
Mar 28, 1998·The New England Journal of Medicine·P B Watkins, R W Whitcomb
May 20, 1998·Liver·K KuboK Okita
Sep 12, 1998·Nature Medicine·P SarrafB M Spiegelman
Sep 12, 1998·Nature Medicine·A M LefebvreJ Auwerx
Sep 12, 1998·Nature Medicine·E SaezR M Evans
Oct 31, 1998·Gastroenterology·J A BrockmanR N Dubois
Oct 31, 1998·Gastroenterology·G D Wu, M A Lazar
Dec 5, 1998·Diabetes Care·A ShibuyaH Takeuchi
Jul 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M NagaoH Nakano
Aug 24, 1999·Journal of Hepatology·M TakahashiH Ishii
Sep 2, 1999·Biochemical and Biophysical Research Communications·J A KeelanM D Mitchell
Mar 29, 2000·British Journal of Cancer·Y ItoN Matsuura
Feb 7, 2001·Biochemical and Biophysical Research Communications·Y TsubouchiM Kondo
Jun 22, 2000·The Journal of Pathology·T RoskamsV Desmet
Jul 21, 2000·Liver·L EverettD Crabb
Sep 13, 2000·Drugs·P S Gillies, C J Dunn
Sep 16, 2000·Journal of Diabetes and Its Complications·H LiK M Klein
Mar 29, 2001·Human Pathology·S H LeeN J Yoo
Mar 30, 2001·Neuroreport·T T RohnD H Cribbs
Apr 12, 2001·European Journal of Immunology·S G Harris, R P Phipps
May 9, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H KogaM Sata
Citations
May 30, 2008·PPAR Research·Ivan Borbath, Yves Horsmans
Nov 10, 2013·PPAR Research·Seung-Won ParkYoung Il Kim
Aug 30, 2012·Biotechnology Journal·Emmanuelle BergerAlain Geloën
Oct 7, 2004·British Journal of Cancer·Y-C ShenA-L Cheng
Aug 30, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Syed Z ImamWei-Dong Le
Sep 26, 2017·Oncology Letters·Zhe JinYahui Liu
Oct 18, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Hiroshi OkanoTakeshi Nakano
Jul 20, 2014·Molecular Biology Reports·Sundas FayyazAmmad Ahmad Farooqi
Aug 8, 2006·Molecular Cancer Therapeutics·Susumu NakataToshiyuki Sakai